Amgen
Jack Lee has over 20 years of experience in oncology research and medical affairs. Currently serving as a Clinical Research Coordinator at Amgen since 2014, Jack focuses on clinical trial planning for soft tissue sarcomas, including Leiomyosarcoma, Liposarcoma, Pleomorphic sarcoma, and Rhabdomyosarcoma, while collaborating with prestigious institutions such as Mass General and Harvard Medical School. Prior to this role, Jack worked as a Global Medical Affairs Leader at AstraZeneca from 2003 to 2014 and as a Postdoctoral Scientist at Scripps Research from 1999 to 2003. Jack holds an MD in Oncology and Cancer Biology from Baylor College of Medicine and a BS in Molecular Biology from Vanderbilt University.